Angiogenesis inhibitory antibodies
US5677181A · kind A · utility
85Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 3, 1995 |
| Grant date | Oct 14, 1997 |
| Priority date | — |
| Expiry date | Jul 3, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies, including monoclonal antibodies, specific for proliferating/angiogenic human endothelial cells such as human umbilical vein endothelial cells and human umbilical artery endothelial cells, and conjugates of these antibodies with a toxin material or label, are useful for inhibition of angiogenesis or for treatment of angiogenesis-dependent disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.